WACKER Strengthens Biologics Business by Acquiring US-Based Plasmid DNA Manufacturer Genopis
· WACKER TAKES OVER GENOPIS, HEADQUARTERED IN SAN DIEGO, CALIFORNIA (USA) · GENOPIS’ EXPERTISE IN PLASMID DNA TECHNOLOGY EXPANDS WACKER’S PORTFOLIO AS A CONTRACT MANUFACTURER FOR THE PHARMACEUTICAL INDUSTRY · PURCHASE PRICE CONSISTS OF A $39 MILLION UPFRONT PAYMENT AND FURTHER PERFORMANCE-RELATED PAYMENTS · CEO RUDOLF STAUDIGL: “ACQUISITION EXPANDS WACKER'S PORTFOLIO AND CAPACITIES AND CREATES A PRESENCE IN THE IMPORTANT US BIOPHARMA MARKET”För mer information se bifogad pressrelease.